Thyroid Gland PDF
Document Details
Uploaded by BetterMajesty7393
UMST
Tags
Summary
This document provides an overview of the thyroid gland, covering various conditions such as hyperthyroidism, Graves's disease, and hypothyroidism, as well as potential medical treatments. It explains the symptoms and root causes related to these conditions. It's a useful reference for medical professionals and students.
Full Transcript
# THYROID GLAND ## I. THYROGLOSSAL DUCT CYST - **A.** Cystic dilation of thyroglossal duct remnant - 1. Thyroid develops at the base of tongue and then travels along the thyroglossal duct to the anterior neck. - 2. Thyroglossal duct normally involutes; a persistent duct, however, may under...
# THYROID GLAND ## I. THYROGLOSSAL DUCT CYST - **A.** Cystic dilation of thyroglossal duct remnant - 1. Thyroid develops at the base of tongue and then travels along the thyroglossal duct to the anterior neck. - 2. Thyroglossal duct normally involutes; a persistent duct, however, may undergo cystic dilation. - **B.** Presents as an anterior neck mass ## II. LINGUAL THYROID - **A.** Persistence of thyroid tissue at the base of tongue - **B.** Presents as a base of tongue mass # HYPERTHYROIDISM ## I. BASIC PRINCIPLES - **A.** Increased level of circulating thyroid hormone - 1. Increases basal metabolic rate (due to increased synthesis of Na+-K+ ATPase) - 2. Increases sympathetic nervous system activity (due to increased expression of __β₁-adrenergic receptors__) - **B.** Clinical features include - 1. Weight loss despite increased appetite - 2. Heat intolerance and sweating - 3. Tachycardia with increased cardiac output - 4. Arrhythmia (e.g., atrial fibrillation), especially in the elderly - 5. Tremor, anxiety, insomnia, and heightened emotions - 6. Staring gaze with lid lag - 7. Diarrhea with malabsorption - 8. Oligomenorrhea - 9. Bone resorption with hypercalcemia (risk for osteoporosis) - 10. Decreased muscle mass with weakness - 11. Hypocholesterolemia - 12. Hyperglycemia (due to gluconeogenesis and glycogenolysis) ## II. GRAVES DISEASE - **A.** Autoantibody (IgG) that stimulates TSH receptor (type II hypersensitivity) - **B.** Leads to increased synthesis and release of thyroid hormone - 1. Most common cause of hyperthyroidism - 2. Classically occurs in women of childbearing age (20-40 years) - **C.** Clinical features include - 1. Hyperthyroidism - 2. Diffuse goiter - Constant TSH stimulation leads to thyroid hyperplasia and hypertrophy (Fig. 15.1A). - 3. Exophthalmos and pretibial myxedema - i. Fibroblasts behind the orbit and overlying the shin express the TSH receptor. - ii. TSH activation results in glycosaminoglycan (chondroitin sulfate and hyaluronic acid) buildup, inflammation, fibrosis, and edema leading to exophthalmos and pretibial myxedema. - 4. Irregular follicles with scalloped colloid and chronic inflammation are seen on histology (Fig. 15.18). - **D.** Laboratory findings include - 1. __↑__ total and free T₄; __↓__ TSH (free T₄ downregulates TRH receptors in the anterior pituitary to decrease TSH release) - 2. Hypocholesterolemia - 3. Increased serum glucose - **E.** Treatment involves β- blockers, thioamide, and radioiodine ablation. - **F.** Thyroid storm is a potentially fatal complication. - 1. Due to elevated catecholamines and massive hormone excess, usually in response to stress (e.g., surgery or childbirth) - 2. Presents as arrhythmia, hyperthermia, and vomiting with hypovolemic shock - 3. Treatment is propylthiouracil (PTU), β- blockers, and steroids. - i. PTU inhibits peroxidase-mediated oxidation, organification, and coupling steps of thyroid hormone synthesis, as well as peripheral conversion of T₄ to T₃. ## III. MULTINODULAR GOITER - **A.** Enlarged thyroid gland with multiple nodules (Fig. 15.2) - **B.** Due to relative iodine deficiency - **C.** Usually nontoxic (euthyroid) - **D.** Rarely, regions become TSH-independent leading to T₄ release and hyperthyroidism ('toxic goiter'). # HYPOTHYROIDISM ## I. CRETINISM - **A.** Hypothyroidism in neonates and infants - **B.** Characterized by mental retardation, short stature with skeletal abnormalities, coarse facial features, enlarged tongue, and umbilical hernia - 1. Thyroid hormone is required for normal brain and skeletal development. - **C.** Causes include maternal hypothyroidism during early pregnancy, thyroid agenesis, dyshormonogenetic goiter, and iodine deficiency. - 1. Dyshormonogenetic goiter is due to a congenital defect in thyroid hormone production; most commonly involves thyroid peroxidase ## II. MYXEDEMA - **A.** Hypothyroidism in older children or adults - **B.** Clinical features are based on decreased basal metabolic rate and decreased sympathetic nervous system activity. - 1. Myxedema - accumulation of glycosaminoglycans in the skin and soft tissue; results in a deepening of voice and large tongue - 2. Weight gain despite normal appetite - 3. Slowing of mental activity - 4. Muscle weakness - 5. Cold intolerance with decreased sweating - 6. Bradycardia with decreased cardiac output, leading to shortness of breath and fatigue - 7. Oligomenorrhea - 8. Hypercholesterolemia - 9. Constipation - **C.** Most common causes are iodine deficiency and Hashimoto thyroiditis; other causes include drugs (e.g., lithium) and surgical removal or radioablation of the thyroid. # THYROIDITIS ## I. HASHIMOTO THYROIDITIS - **A.** Autoimmune destruction of the thyroid gland; associated with HLA-DR5 - 1. Most common cause of hypothyroidism in regions where iodine levels are adequate - **B.** Clinical features - 1. Initially may present as hyperthyroidism (due to follicle damage) - 2. Progresses to hypothyroidism; ↑ T₄ and ↑ TSH - 3. Antithyroglobulin and antithyroid peroxidase antibodies are often present (sign of thyroid damage). - **C.** Chronic inflammation with germinal centers and Hurthle cells (eosinophilic metaplasia of cells that line follicles) is seen on histology (Fig. 15.3). - **D.** Increased risk for B-cell (marginal zone) lymphoma; presents as an enlarging thyroid gland late in disease course ## II. SUBACUTE GRANULOMATOUS (DE QUERVAIN) THYROIDITIS - **A.** Granulomatous thyroiditis that follows a viral infection - **B.** Presents as a tender thyroid with transient hyperthyroidism - **C.** Self- limited; rarely (15% of cases) may progress to hypothyroidism ## III. RIEDEL FIBROSING THYROIDITIS - **A.** Chronic inflammation with extensive fibrosis of the thyroid gland - **B.** Presents as hypothyroidism with a 'hard as wood, nontender thyroid gland - **C.** Fibrosis may extend to involve local structures (e.g., airway). - 1. Clinically mimics anaplastic carcinoma, but patients are younger (40s) and malignant cells are absent # THYROID NEOPLASIA ## I. BASIC PRINCIPLES - **A.** Usually presents as a distinct, solitary nodule - **B.** - 1. Thyroid nodules are more likely to be benign than malignant. - 2. ¹³¹I radioactive uptake studies are useful to further characterize nodules. - 1. Increased uptake ('hot' nodule) is seen in Graves disease or nodular goiter. - 2. Decreased uptake ('cold' nodule) is seen in adenoma and carcinoma; often warrants biopsy - **C.** Biopsy is performed by fine needle aspiration (FNA). ## II. FOLLICULAR ADENOMA - **A.** Benign proliferation of follicles surrounded by a fibrous capsule (Fig. 15.4) - **B.** Usually nonfunctional; less commonly, may secrete thyroid hormone ## III. PAPILLARY CARCINOMA - **A.** Most common type of thyroid carcinoma (80% of cases) - **B.** Exposure to ionizing radiation in childhood is a major risk factor. - **C.** Comprised of papillae lined by cells with clear, 'Orphan Annie eye' nuclei and nuclear grooves (Fig. 15.5A); papillae are often associated with psammoma bodies (Fig. 15.5B). - **D.** Often spreads to cervical (neck) lymph nodes, but prognosis is excellent (10-year survival > 95%) ## IV. FOLLICULAR CARCINOMA - **A.** Malignant proliferation of follicles surrounded by a fibrous capsule with invasion through the capsule (Fig. 15.6) - 1. Invasion through the capsule helps distinguish follicular carcinoma from follicular adenoma. - 2. Entire capsule must be examined microscopically. - 3. FNA only examines cells and not the capsule; hence, a distinction between follicular adenoma and follicular carcinoma cannot be made by FNA. - **B.** Metastasis generally occurs hematogenously. ## V. MEDULLARY CARCINOMA - **A.** Malignant proliferation of parafollicular C cells; comprises 5% of thyroid carcinomas - 1. C cells are neuroendocrine cells that secrete calcitonin. - 2. Calcitonin lowers serum calcium by increasing renal calcium excretion but is inactive at normal physiologic levels. - 3. High levels of calcitonin produced by tumor may lead to hypocalcemia. - 4. Calcitonin often deposits within the tumor as amyloid. - **B.** Biopsy reveals sheets of malignant cells in an amyloid stroma (Fig. 15.7). - **C.** Familial cases are often due to multiple endocrine neoplasia (MEN) 2A and 2B, which are associated with mutations in the RET oncogene. - 1. MEN 2 results in medullary carcinoma, pheochromocytoma, and parathyroid adenomas (2A) or ganglioneuromas of the oral mucosa (2B). - 2. Detection of the RET mutation warrants prophylactic thyroidectomy. ## VI. ANAPLASTIC CARCINOMA - **A.** Undifferentiated malignant tumor of the thyroid (Fig. 15.8); usually seen in elderly - **B.** Often invades local structures, leading to dysphagia or respiratory compromise - **C.** Poor prognosis